Page last updated: 2024-08-20

nerolidol and Cancer of Liver

nerolidol has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baranoski, A; Biazi, BI; Corveloni, AC; Mantovani, MS; Zanetti, TA	1

Other Studies

1 other study(ies) available for nerolidol and Cancer of Liver

Article	Year
Cis-Nerolidol Induces Endoplasmic Reticulum Stress and Cell Death in Human Hepatocellular Carcinoma Cells through Extensive CYP2C19 and CYP1A2 Oxidation. Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:4 Topics: Activation, Metabolic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Oxidation-Reduction; Sesquiterpenes; Time Factors	2017

Article

Year

Cis-Nerolidol Induces Endoplasmic Reticulum Stress and Cell Death in Human Hepatocellular Carcinoma Cells through Extensive CYP2C19 and CYP1A2 Oxidation.

Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:4

Topics: Activation, Metabolic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Oxidation-Reduction; Sesquiterpenes; Time Factors

2017